Skip to main content
Intermediate Technical IVT

variant of uncertain significance

Also written as: VUS — variant of uncertain significance

A genetic alteration whose impact on protein function and clinical significance cannot be definitively determined.

Full Definition

Variants of uncertain significance (VUS) represent genetic changes where current evidence is insufficient to classify them as pathogenic or benign. In oncology informatics, VUS classification follows guidelines from the Association for Molecular Pathology and presents challenges for clinical interpretation. These variants require ongoing surveillance as new evidence emerges. Editorial teams must understand that VUS reporting requires careful language to avoid overinterpretation by clinicians and patients.

Usage

Usage note: Prefer full term in formal documents; VUS acceptable in informal contexts but define on first use.

In Context

  • "The laboratory classified the novel BRCA2 missense mutation as a variant of uncertain significance pending functional studies." — Genetic counseling report
  • "Updated classification guidelines have reclassified 23% of historical variants of uncertain significance as likely benign." — Laboratory quality assurance document

Also known as

VUS variant of unknown significance uncertain variant

Contrasted with

pathogenic variant benign variant

Don't confuse with

likely pathogenic variant variant of unknown clinical significance

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON